Nurix Therapeutics (NRIX) EBITDA Margin (2019 - 2026)
Nurix Therapeutics (NRIX) reported EBITDA Margin of -1016.80% for fiscal Q2 2026 (quarter ended May 31, 2026), down 912.20 percentage points from -104.59% a year earlier but up 427.52 percentage points from the prior quarter.
Nurix Therapeutics (NRIX) EBITDA Margin (2019 - 2026) Analysis & Trends
Over the twelve months ended May 31, 2026, Nurix Therapeutics' EBITDA Margin came in at -958.98%, down 709.02 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it was -329.75%, up 43.69 percentage points from FY2024.
- EBITDA Margin has a five-year change of +22.57 percentage points (FY2020 to FY2025).
- By fiscal year, EBITDA Margin came in at -373.44% in FY2024 (-181.81 pp), -191.63% in FY2023 (+270.53 pp), -462.16% in FY2022 (-75.31 pp) and -386.84% in FY2021 (-34.53 pp).
- Five-year quarterly EBITDA Margin spans a low of -1444.32% in fiscal Q1 2026 and a high of -81.07% in fiscal Q2 2023.
- Year over year, EBITDA Margin has now declined in each of the last four quarters, with an average year-over-year change of -381.83 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was fiscal Q4 2023 (a gain of 407.66 percentage points); the low point was fiscal Q1 2026 (a drop of 1116.39 percentage points).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at -1444.32% (Q1 2026), -596.41% (Q4 2025) and -1131.96% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | -1,016.80% |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1,016.80% |
| Feb 28, 2026 | -1,444.32% |
| Nov 30, 2025 | -596.41% |
| Aug 31, 2025 | -1,131.96% |
| May 31, 2025 | -104.59% |
| Feb 28, 2025 | -327.94% |
| Nov 30, 2024 | -467.54% |
| Aug 31, 2024 | -414.82% |
| May 31, 2024 | -382.15% |
| Feb 29, 2024 | -260.32% |
| Nov 30, 2023 | -286.30% |
| Aug 31, 2023 | -206.10% |
| May 31, 2023 | -81.07% |
| Feb 28, 2023 | -324.79% |
| Nov 30, 2022 | -693.96% |
| Aug 31, 2022 | -419.03% |
| May 31, 2022 | -388.51% |
| Feb 28, 2022 | -433.98% |
| Nov 30, 2021 | -502.79% |
| Aug 31, 2021 | -276.01% |
Nurix Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();